Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
E3 ubiquitin-protein ligase that accepts ubiquitin from the E2 ubiquitin-conjugating enzyme UBE2D1 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Additionally we are shipping UBE3C Antibodies (34) and and many more products for this protein.
Showing 3 out of 4 products:
Usp14 and Ube3c cycle together on and off proteasomes, and the presence of ubiquitinated substrates promotes their association. This mechanism enables proteasome activity to adapt to the supply of substrates.
miR (show MLXIP Proteins)-542-3p functioned as a tumor suppressor gene in regulating the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via targeting UBE3C.
UBE3C promotes melanoma progression, possibly by inducing epithelial-mesenchymal transition in melanoma cells
Ectopic overexpression of UBE4A, but not UBE3C, in cells was downregulated in vitro migration and invasion in these cells. Cumulatively, our data reveals a novel post-translational regulatory mechanism of regulating ILEI1 expression, a protein required for metastatic progression in prostate cancer cells
data reveal that high UBE3C expression contributes to glioma progression by ubiquitination and degradation of ANXA7 (show ANXA7 Proteins), and thus presents a novel and promising target for glioma therapy.
these observations suggest that UBE3C plays an important role in RCC (show XRCC1 Proteins) development and progression, and UBE3C may be a novel target for prevention and treatment of ccRCC.
UBE3C is a mutant candidate oncogene (show RAB1A Proteins) involved in tumor development and progression of hepatocellular carcinoma.
knockdown renders cells more susceptible to the Hsp90 (show HSP90 Proteins) inhibitor 17-AAG (show MPG Proteins), suggesting that UBE3C protects against the harmful accumulation of protein fragments arising from incompletely degraded proteasome substrates.
Our findings provide evidence that variations in UBE3C are potent genetic markers of nasal polyps development in Korean asthmatics.
negatively regulates type I interferon (show IFNA Proteins) through ubiquitination of the transcription factors
E3 ubiquitin-protein ligase that accepts ubiquitin from the E2 ubiquitin-conjugating enzyme UBE2D1 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Can assemble unanchored poly-ubiquitin chains in either 'Lys-29'- or 'Lys-48'-linked polyubiquitin chains. Has preference for 'Lys-48' linkages. It can target itself for ubiquitination in vitro and may promote its own degradation in vivo.
ubiquitin-protein ligase E3C
, ubiquitin protein ligase E3C
, ubiquitin-protein isopeptide ligase (E3)
, ubiquitin-protein ligase E3C-like